RHAMM is a cell surface receptor expressed in tumor cells in AML, MDS, CML, CLL (chronic lymphocytic leukemia) and MM (multiple myeloma) patients [47]. Here, HMMR is linked to B-cell chronic lymphocytic leukemia.